InMode Ltd vs Nano Dimension Ltd - ADR — how do they compare? InMode Ltd trades at $15.34 (market cap $882.90M), while Nano Dimension Ltd - ADR trades at $1.5 (market cap $322.08M). The key difference: InMode Ltd is far larger — about 2.7× Nano Dimension Ltd - ADR's market cap, and InMode Ltd is trading nearer its 52-week high, Nano Dimension Ltd - ADR nearer its low. Which is the better fit depends on your goals.
| INMD | NNDM | |
|---|---|---|
Market Cap | $882.90M | $322.08M |
Sector | Technology | Technology |
52-Week High | $16.62 | $2.14 |
52-Week Low | $12.76 | $1.21 |
Enterprise Value | $350.57M | -$87.26M |
Signals from Pluang's Aura AI — not financial advice
INMD trades at $15.36, down 0.71% on the day, with a bullish technical signal from moving averages but a neutral reading from oscillators. The company maintains strong profitability with a 77.84% gross margin and 23.27% net margin, though Q1 2026 earnings missed expectations. Recent news includes an unsolicited acquisition offer of $16.75 per share from Steel Partners and upcoming Q2 2026 results on August 5, 2026.
The stock presents a mixed outlook: attractive valuation multiples and a solid balance sheet support upside, but risks include earnings volatility, shareholder activism, and a securities fraud investigation. Analyst consensus is a $16.50 price target with a balanced buy/hold rating split, suggesting cautious optimism near-term.
NNDM trades at $1.545, down 0.32% today, with a bearish technical signal from moving averages. The company reported 2025 revenue of $102.44M but a net loss of $293.30M, reflecting a -286.72% net margin. Cash flow remains negative at -$112.07M, though the balance sheet shows $757.96M in cash against minimal debt. Recent news highlights cost-saving initiatives and a proposed merger with Infinite Epigenetics amid shareholder disputes with Murchinson.
Outlook remains challenged by persistent losses and cash burn, but the strong cash position provides a buffer. The proposed merger introduces strategic uncertainty. Key risks include execution on profitability and shareholder alignment. Analyst sentiment is cautious given the fundamental weaknesses and ongoing corporate actions.
Trailing returns across standard periods
Latest headlines on both assets
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →